Immunome (IMNM) Director Carol Schafer Receives Option Award

What Happened

• Carol Schafer, a director of Immunome Inc. (IMNM), received a derivative award on 2026-06-10: an option covering 9,897 shares with a $0.00 grant price. This was a grant/award (not an open-market purchase or sale), so no shares were sold or immediately transferred.

Key Details

• Transaction date: 2026-06-10; SEC filing date: 2026-06-12 (timely, within typical 2-business-day reporting window).
• Award: 9,897 option shares; reported price $0.00 (grant of an option/award, not an exercised purchase).
• Shares owned following the reported transaction: not specified in the filing.
• Footnote (vesting): The option vests in four equal quarterly installments, commencing June 10, 2026 and finishing on the one-year anniversary (same day each fiscal quarter), subject to Schafer’s continuous service.
• No 10b5-1 plan, tax withholding sale, or immediate cashless exercise was reported in this filing.

Context

• This is a director compensation award: a derivative grant with a scheduled vesting timeline. Such awards create potential future dilution only as and when options vest and are exercised; they do not represent an immediate change in outstanding common shares.